Skip to main content
CGNX
NASDAQ Industrial Applications And Services

Cognex Confirms Strong Q1 Results, Details Dilutive Stock Plan & Minor Business Divestiture

Analysis by Arik Shkolnikov
Sentiment info
Neutral
Importance info
7
Price
$66.5
Mkt Cap
$10.398B
52W Low
$27.61
52W High
$63.01
Market data snapshot near publication time

summarizeSummary

Cognex Corporation filed its Q1 2026 10-Q, confirming robust financial performance with significant revenue and EPS growth, while also disclosing shareholder approval for a dilutive increase in its stock option plan and details of a non-core business divestiture.


check_boxKey Events

  • Strong Q1 Financial Performance Confirmed

    Revenue increased 24% to $268.4 million, and diluted EPS grew 121% to $0.31 year-over-year, confirming previously announced results for the quarter ended April 5, 2026.

  • Dilutive Stock Option Plan Expansion Approved

    Shareholders approved an amendment to the 2023 Stock Option and Incentive Plan on April 29, 2026, increasing the maximum amount of shares available for issuance by 4.6 million. This represents a potential dilution of approximately 2.76% to current outstanding shares.

  • Non-Core Business Divestiture Completed

    On April 1, 2026, the company completed the divestiture of its Japan-focused trading business for gross proceeds of $12.05 million, recognizing a pre-tax loss of $1.54 million. This business accounted for approximately 2% of overall revenue in 2025.

  • Share Repurchase Program Update

    The company repurchased $99.0 million in common stock during the quarter, with $16.0 million remaining under the current authorization. An additional $500 million program was authorized on February 11, 2026, to commence upon completion of the existing program.


auto_awesomeAnalysis

This 10-Q provides the full unaudited financial statements for the first quarter of 2026, confirming the strong results previously announced in an 8-K. Key highlights include a 24% increase in revenue and a 121% surge in diluted EPS year-over-year. However, the filing also reveals that shareholders approved an amendment to the 2023 Stock Option and Incentive Plan, increasing available shares by 4.6 million. This represents a potential dilution of approximately 2.76% to existing shareholders, which is a notable negative counterbalancing the positive earnings. Additionally, the company completed the divestiture of its Japan-focused trading business for $12.05 million, incurring a pre-tax loss of $1.54 million, though this was a non-core asset and not considered strategically material. Investors should weigh the confirmed strong operational performance against the potential future dilution from the expanded stock plan.

At the time of this filing, CGNX was trading at $66.50 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $10.4B. The 52-week trading range was $27.61 to $63.01. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CGNX - Latest Insights

CGNX
May 07, 2026, 6:30 AM EDT
Filing Type: 10-Q
Importance Score:
7
CGNX
May 06, 2026, 4:54 PM EDT
Source: Reuters
Importance Score:
8
CGNX
May 06, 2026, 4:32 PM EDT
Filing Type: 8-K
Importance Score:
8
CGNX
May 06, 2026, 4:30 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
CGNX
Mar 13, 2026, 8:01 AM EDT
Filing Type: DEF 14A
Importance Score:
7
CGNX
Feb 24, 2026, 4:29 PM EST
Filing Type: 4
Importance Score:
7
CGNX
Feb 17, 2026, 8:01 AM EST
Filing Type: 8-K
Importance Score:
7
CGNX
Feb 12, 2026, 6:14 AM EST
Filing Type: 10-K
Importance Score:
8
CGNX
Feb 11, 2026, 4:31 PM EST
Filing Type: 8-K
Importance Score:
9